SCHEMBL26592003

SCHEMBL26592003

N#Cc1cccc(-c2cccc(-c3nc(-c4ccc(-c5ccc(-c6ccccc6)cc5)cc4)nc(-c4cc(-c5ccccc5)ccc4-c4ccccc4)n3)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.51
CYP3A4 P08684 7/20 0.51
CLK4 Q9HAZ1 5/20 0.51
LMNA P02545 5/20 0.51
CYP2D6 P10635 5/20 0.51
MEN1 O00255 4/20 0.51
ALDH1A1 P00352 4/20 0.51
KMT2A Q03164 4/20 0.51
CYP2C19 P33261 4/20 0.51
HSD17B10 Q99714 3/20 0.51
TSHR P16473 3/20 0.51
CYP2C9 P11712 2/20 0.51
MAPK1 P28482 2/20 0.48
TP53 P04637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
ALDH1A3 P47895 1/20 0.46
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27368619 1.00 CYP1A2 (0.51) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL26592001 1.00 CYP1A2 (0.51) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL26591982 0.97 CLK4 (0.50) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL27368554 0.96 CYP1A2 (0.50) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL27368549 0.96 CYP1A2 (0.50) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL27453831 0.95 CYP1A2 (0.47) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL26592012 0.95 CYP1A2 (0.49) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL25872009 0.94 CYP1A2 (0.51) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL27453615 0.94 CYP1A2 (0.51) CYP1A2CYP3A4CLK4LMNACYP2D6
SCHEMBL26277123 0.94 CYP1A2 (0.51) CYP1A2CYP3A4CLK4LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 US disclosed
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE ARNT, TPH1, AHR CYP1A2 15/4885CYP3A4 347/4885CLK4 2450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.